AS (@ren_familia) 's Twitter Profile
AS

@ren_familia

Nephrologist. Alma mater @aiims_newdelhi. Firm believer in Poe’s law and it’s corollary. Student for life. GlomCon 2022| NSMC 2023.

ID: 1152865980168564736

calendar_today21-07-2019 09:00:43

618 Tweet

434 Takipçi

772 Takip Edilen

AS (@ren_familia) 's Twitter Profile Photo
AS
@ren_familia

3 months ago

20/n MITIGATE trial- Inebilizumab 💊 Excellent steroid response early 🛡️ Immunosuppression for relapsers 💉 Inebilizumab – 1st FDA-approved drug for IgG4-RD 💰 Costly (~$150k/30 mL) 📖nejm.org/doi/full/10.10… #ECNeph manjusha yadla Milagros Flores Dilushi Wijayaratne Fong Voon Ken Int Society of Nephrology

20/n MITIGATE trial- Inebilizumab 💊 Excellent steroid response early 🛡️ Immunosuppression for relapsers 💉 Inebilizumab – 1st FDA-approved drug for IgG4-RD 💰 Costly (~$150k/30 mL) 📖nejm.org/doi/full/10.10… #ECNeph <a href="/myadla/">manjusha yadla</a> <a href="/dra_miliflores/">Milagros Flores</a> <a href="/Dilushiwijay/">Dilushi Wijayaratne</a> <a href="/Ironken6/">Fong Voon Ken</a> <a href="/ISNkidneycare/">Int Society of Nephrology</a>